Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods
Abstract Background In malaria endemic countries of sub-Saharan Africa, many children develop severe anaemia due to previous and current malaria infections. After blood transfusions and antimalarial treatment at the hospital they are usually discharged without any follow-up. In the post-discharge pe...
Main Authors: | Sarah Svege, Blessings Kaunda, Bjarne Robberstad, Thandile Nkosi-Gondwe, Kamija S. Phiri, Siri Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-018-3327-z |
Similar Items
-
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial
by: Thandile Gondwe, et al.
Published: (2018-07-01) -
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial
by: Thandile Nkosi-Gondwe, et al.
Published: (2023-04-01) -
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers’ perceptions and motivation
by: Thandile Nkosi-Gondwe, et al.
Published: (2018-12-01) -
Choreoathetosis – an unusual adverse effect of dihydroartemisinin-piperaquine: a case report
by: Benjamin Momo Kadia, et al.
Published: (2017-12-01) -
A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)